Free Trial
Jonathan Bock

Jonathan Bock Analyst Performance

Managing Director Medical Technology & Supplies at Stifel Nicolaus

Jonathan Bock is a stock analyst at Stifel Nicolaus focused in the finance sector, covering 4 publicly traded companies. Over the past year, Jonathan Bock has issued 1 stock ratings, including and buy recommendations. While full access to Jonathan Bock's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jonathan Bock's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
4 Last 10 Years
Buy Recommendations
50.00% 2 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%2 ratings
Hold25.0%1 ratings
Sell25.0%1 ratings

Out of 4 total stock ratings issued by Jonathan Bock at Stifel Nicolaus, the majority (50.0%) have been Buy recommendations, followed by 25.0% Hold and 25.0% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.0% of companies on NASDAQ
3 companies
NYSE
25.0% of companies on NYSE
1 company

Jonathan Bock, an analyst at Stifel Nicolaus, currently covers 4 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Finance
3 companies
75.0%
Medical
1 company
25.0%

Jonathan Bock of Stifel Nicolaus specializes in stock coverage within the Finance sector, with additional focus on Medical companies.

Coverage Industries

IndustryPercentage
FIN - SBIC&COMMRL
2 companies
50.0%
MED PRODUCTS
1 company
25.0%
FIN - INVEST MGMT
1 company
25.0%

About Jonathan Bock

Jonathan Block joined Stifel in 2012. Based out of the New York office, Mr. Block is a Managing Director in the Healthcare sector, covering Medical Technology & Supplies. Before joining Stifel, Mr. Block was with SunTrust Robinson Humphrey as an analyst and Banc of America Securities on the institutional investor team. Mr. Block is a graduate of Tulane University.
Follow on LinkedIn

Jonathan Bock's Ratings History at Stifel Nicolaus

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Envista Holdings Corporation stock logo
NVST
Envista
8/1/2025Boost Price Target$20.71$25.00Buy